|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:alsoKnownAs
|
gptkb:Merck_Sharp_&_Dohme
gptkb:Merck_&_Co.
|
|
gptkbp:CEO
|
gptkb:Robert_M._Davis
|
|
gptkbp:competitor
|
gptkb:Pfizer
gptkb:AstraZeneca
gptkb:Eli_Lilly_and_Company
gptkb:Johnson_&_Johnson
gptkb:Sanofi
gptkb:AbbVie
gptkb:Novartis
gptkb:Roche
gptkb:Bristol_Myers_Squibb
GlaxoSmithKline
|
|
gptkbp:countryOfOrigin
|
gptkb:United_States
|
|
gptkbp:founded
|
1891
|
|
gptkbp:founder
|
gptkb:George_Merck
|
|
gptkbp:headquartersLocation
|
gptkb:Kenilworth,_New_Jersey,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
MSD (Merck & Co.)
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:legalForm
|
gptkb:public_company
|
|
gptkbp:memberOf
|
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America_(PhRMA)
gptkb:International_Federation_of_Pharmaceutical_Manufacturers_&_Associations_(IFPMA)
|
|
gptkbp:notableContributor
|
gptkb:diabetes
antibiotics
infectious diseases
oncology
vaccines
|
|
gptkbp:notableEvent
|
acquired Schering-Plough in 2009
developed first HPV vaccine
developed first hepatitis B vaccine
developed first measles vaccine
developed first mumps vaccine
developed first rubella vaccine
involved in Vioxx litigation
developed ivermectin (Mectizan)
spun off Organon & Co. in 2021
|
|
gptkbp:numberOfEmployees
|
~69,000 (2023)
|
|
gptkbp:parentCompany
|
Merck Group (historically, in Germany only)
|
|
gptkbp:products
|
gptkb:Lynparza
gptkb:Bridion
gptkb:Cubicin
gptkb:Gardasil
gptkb:Isentress
gptkb:Januvia
gptkb:Keytruda
gptkb:Propecia
gptkb:Simponi
gptkb:Singulair
gptkb:Zetia
|
|
gptkbp:publiclyTraded
|
yes
|
|
gptkbp:rank
|
gptkb:Fortune_500
|
|
gptkbp:revenue
|
$59.3 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:MRK
|
|
gptkbp:subsidiary
|
Organon & Co. (spun off 2021)
|
|
gptkbp:website
|
https://www.merck.com/
|
|
gptkbp:bfsParent
|
gptkb:Diosynth
|
|
gptkbp:bfsLayer
|
7
|